These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33434612)

  • 1. A Genotype Signature for Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer.
    Xiao WW; Li M; Guo ZW; Zhang R; Xi SY; Zhang XG; Li Y; Wu DQ; Ren YF; Pang XL; Wan XB; Li K; Zhou CL; Zhai XM; Liang ZK; Wang QX; Zeng ZF; Zhang HZ; Yang XX; Wu YS; Li M; Gao YH
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):482-491. PubMed ID: 33434612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
    Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic variations using whole-exome sequencing might predict response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Lee IH; Kang K; Kang BW; Lee SJ; Bae WK; Hwang JE; Kim HJ; Park SY; Park JS; Choi GS; Kim JG
    Med Oncol; 2018 Sep; 35(11):145. PubMed ID: 30206710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response prediction of neoadjuvant chemoradiation therapy in locally advanced rectal cancer using CT-based fractal dimension analysis.
    Tochigi T; Kamran SC; Parakh A; Noda Y; Ganeshan B; Blaszkowsky LS; Ryan DP; Allen JN; Berger DL; Wo JY; Hong TS; Kambadakone A
    Eur Radiol; 2022 Apr; 32(4):2426-2436. PubMed ID: 34643781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
    Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer.
    Zhang S; Zhang R; Li RZ; Wang QX; Chang H; Ding PR; Li LR; Wu XJ; Chen G; Zeng ZF; Xiao WW; Gao YH
    Cancer Sci; 2021 Sep; 112(9):3607-3615. PubMed ID: 34146368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer.
    Seo I; Lee HW; Byun SJ; Park JY; Min H; Lee SH; Lee JS; Kim S; Bae SU
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
    Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction and validation of pathologic complete response for locally advanced rectal cancer under neoadjuvant chemoradiotherapy based on a novel predictor using interpretable machine learning.
    Wang Y; Pan Z; Li S; Cai H; Huang Y; Zhuang J; Liu X; Lu X; Guan G
    Eur J Surg Oncol; 2024 Dec; 50(12):108738. PubMed ID: 39395242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study.
    Wang Y; Yang L; Bao H; Fan X; Xia F; Wan J; Shen L; Guan Y; Bao H; Wu X; Xu Y; Shao Y; Sun Y; Tong T; Li X; Xu Y; Cai S; Zhu J; Zhang Z
    PLoS Med; 2021 Aug; 18(8):e1003741. PubMed ID: 34464382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Dose-Escalated Chemoradiation on Complete Tumor Response in Patients with Locally Advanced Rectal Cancer (RECTAL-BOOST): A Phase 2 Randomized Controlled Trial.
    Couwenberg AM; Burbach JPM; Berbee M; Lacle MM; Arensman R; Raicu MG; Wessels FJ; Verdult J; Roodhart J; Reerink O; Hoendervangers S; Buijsen J; Grabsch HI; Pronk A; Consten ECJ; Smits AB; Heikens JT; Appelt AL; van Grevenstein WMU; Verkooijen HM; Intven MPW
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1008-1018. PubMed ID: 32565319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External Validation of Early Regression Index (ERI
    Cusumano D; Boldrini L; Yadav P; Yu G; Musurunu B; Chiloiro G; Piras A; Lenkowicz J; Placidi L; Broggi S; Romano A; Mori M; Barbaro B; Azario L; Gambacorta MA; De Spirito M; Bassetti MF; Yang Y; Fiorino C; Valentini V
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1347-1356. PubMed ID: 32758641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy.
    Kim JW; Kim HC; Park JW; Park SC; Sohn DK; Choi HS; Kim DY; Chang HJ; Baek JY; Kim SY; Kim SK; Oh JH
    Int J Colorectal Dis; 2013 Sep; 28(9):1217-24. PubMed ID: 23404344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local tuning of radiomics-based model for predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Tang B; Lenkowicz J; Peng Q; Boldrini L; Hou Q; Dinapoli N; Valentini V; Diao P; Yin G; Orlandini LC
    BMC Med Imaging; 2022 Mar; 22(1):44. PubMed ID: 35287607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
    Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
    Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of Endorectal Endoscopic Ultrasound (EUS) for Locally Advanced Rectal Cancer (LARC) Restaging After Neoadjuvant Chemoradiotherapy (NAT): A Meta-Analysis.
    Zhao YL; Cao DM; Zhou QC; Yang N; Yao HL
    Hepatogastroenterology; 2014 Jun; 61(132):978-83. PubMed ID: 26158152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer.
    Ren DL; Li J; Yu HC; Peng SY; Lin WD; Wang XL; Ghoorun RA; Luo YX
    World J Gastroenterol; 2019 Jan; 25(1):118-137. PubMed ID: 30643363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.